Document Type : case report
Authors
- Mohammad Ali Kiani 1
- Arefeh Abavisani 1
- Hamid Reza Kianifar 1
- Ali Jafari 1
- Maryam Khaleesi 1
- Sayyed Amir Hossein Ghazizadeh Hashemi 2
- Zahra Sabbagh 3
1 Department of Pediatric Gastroenterology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
2 Department of Otolaryngology, Loghman Educational Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
3 Department of Anesthesia, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract
Background and Objective: Moyamoya disease is a condition caused by the obstruction of intracranial vessels, which can lead to ischemic or hemorrhagic vascular events. Most patients have underlying risk factors that contribute to the development of this vascular disease. This article presents a case of Moyamoya disease associated with esophageal achalasia in an 11-year-old boy with a family history of the condition. Comprehensive examinations of this patient did not reveal any complications other than achalasia as a risk factor.
Keywords
- Provenza CG, Romanelli JR. Achalasia: diagnosis and management. Surgical Clinics. 2025 Feb 1;105(1):143-58.
- Ihara M, Yamamoto Y, Hattori Y, Liu W, Kobayashi H, Ishiyama H, et al. Moyamoya disease: diagnosis and interventions. The Lancet Neurology. 2022 Aug 1;21(8):747-58.
- Shang S, Zhou D, Ya J, Li S, Yang Q, Ding Y, et al. Progress in moyamoya disease. Neurosurgical review. 2020 Apr;43:371-82.
- Demartini Jr Z, Teixeira BC, Koppe GL, Gatto LA, Roman A, Munhoz RP. Moyamoya disease and syndrome: a review. Radiologia Brasileira. 2022 Feb 9;55:31-7.
- Gupta A, Tyagi A, Romo M, Amoroso KC, Sonia FN. Moyamoya disease: a review of current literature. Cureus. 2020 Aug;12(8).
- Ullrich NJ, Robertson R, Kinnamon DD, Scott RM, Kieran MW, Turner CD, et al. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology. 2007 Mar 20;68(12):932-8.
- Kuroda S, Yamamoto S, Funaki T, Fujimura M, Kataoka H, Hishikawa T, et al. Five-year stroke risk and its predictors in asymptomatic moyamoya disease: Asymptomatic Moyamoya Registry (AMORE). Stroke. 2023 Jun;54(6):1494-504.
- Veeravagu A, Guzman R, Patil CG, Hou LC, Lee M, Steinberg GK. Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions. Neurosurgical focus. 2008 Feb 1;24(2):E16.
- Hirano Y, Miyawaki S, Imai H, Hongo H, Ohara K, Dofuku S, et al. Association between the onset pattern of adult moyamoya disease and risk factors for stroke. Stroke. 2020.
- Zhang H, Zheng L, Feng L. Epidemiology, diagnosis and treatment of moyamoya disease. Experimental and therapeutic medicine. 2019 Mar 1;17(3):1977-84.
- Fung LW, Thompson D, Ganesan V. Revascularisation surgery for paediatric moyamoya: a review of the literature. Child's Nervous System. 2005 May;21:358-64.
- Hallemeier CL, Rich KM, Grubb Jr RL, Chicoine MR, Moran CJ, Cross III DT, et al. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke. 2006 Jun 1;37(6):1490-6.
- Hertza J, Loughan A, Perna R, Davis AS, Segraves K, Tiberi NL. Moyamoya disease: a review of the literature. Applied Neuropsychology: Adult. 2014 Jan 1;21(1):21-7.
- Kuroda S, Fujimura M, Takahashi J, Kataoka H, Ogasawara K, Iwama T, et al. Diagnostic criteria for moyamoya disease-2021 revised version. Neurologia medico-chirurgica. 2022 Jul 15;62(7):307-12.
- Sato Y, Kazumata K, Nakatani E, Houkin K, Kanatani Y. Characteristics of moyamoya disease based on national registry data in Japan. Stroke. 2019 Aug;50(8):1973-80.
- on the Pathology RC. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurologia medico-chirurgica. 2012;52(5):245-66.
)